« Back to news listing

ConforMIS Achieves Significant Funding Milestone with $167.7 Million in Series E Financing

ConforMIS, Inc., a privately held medical device company pioneering patient-specific orthopedic implants, announced it has expanded its Series E financing to $167.7 million with participation from top-tier Sovereign Wealth Funds, Government Investment Funds and Private Equity Funds in the U.S., Europe, Asia and the Middle East. ConforMIS will use the funds to expand its commercialization of the iTotalĀ® G2 total knee replacement system in the U.S. and abroad, advance its manufacturing capabilities and invest in new market opportunities.

Read entire article: http://www.conformis.com/About-Us/Pressroom/Press-Details?id=50

« Back to news listing